T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Lam Research
LRCX
$408B
| $1.28B | 0.19% |
84,660,820
+17,306,920
| +26% | +$296M |
|
|
HES
127
DELISTED
Hess
HES
| $1.28B | 0.19% |
17,897,704
-2,857,449
| -14% | -$188M |
|
128
Equifax
EFX
$21.2B
| $1.27B | 0.19% |
9,725,886
-3,700,281
| -28% | -$482M |
|
129
CoStar Group
CSGP
$12.3B
| $1.26B | 0.18% |
29,925,720
-860,640
| -3% | -$36.8M |
|
|
CXO
130
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.25B | 0.18% |
8,178,506
+143,375
| +2% | +$20.2M |
|
131
Abbott
ABT
$192B
| $1.24B | 0.18% |
16,962,166
-1,854,657
| -10% | -$122M |
|
132
Humana
HUM
$46.3B
| $1.22B | 0.18% |
3,616,606
-42,197
| -1% | -$13.7M |
|
133
Johnson Controls International
JCI
$93.6B
| $1.2B | 0.18% |
34,288,785
-1,751,770
| -5% | -$64.6M |
|
134
Norwegian Cruise Line
NCLH
$8.7B
| $1.18B | 0.17% |
20,624,616
-3,513,746
| -15% | -$182M |
|
135
Progressive
PGR
$121B
| $1.16B | 0.17% |
16,392,828
-6,647,080
| -29% | -$428M |
|
136
Occidental Petroleum
OXY
$58.4B
| $1.16B | 0.17% |
14,125,597
+696,906
| +5% | +$56.3M |
|
137
DTE Energy
DTE
$28.7B
| $1.15B | 0.17% |
12,336,990
+434,657
| +4% | +$40.5M |
|
|
BKI
138
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.14B | 0.17% |
21,972,688
+50,360
| +0.2% | +$2.7M |
|
139
Gartner
IT
$11.4B
| $1.13B | 0.16% |
7,106,167
+408,579
| +6% | +$59.2M |
|
140
Gilead Sciences
GILD
$168B
| $1.12B | 0.16% |
14,549,656
-1,717,155
| -11% | -$130M |
|
141
TE Connectivity
TEL
$62.6B
| $1.1B | 0.16% |
12,555,241
+4,499,065
| +56% | +$414M |
|
142
West Pharmaceutical
WST
$24.8B
| $1.1B | 0.16% |
8,937,104
-697,773
| -7% | -$78.3M |
|
|
SAGE
143
DELISTED
Sage Therapeutics
SAGE
| $1.1B | 0.16% |
7,752,634
+120,205
| +2% | +$18.6M |
|
144
Trip.com Group
TCOM
$28.7B
| $1.09B | 0.16% |
29,310,750
+3,768,519
| +15% | +$153M |
|
|
KSU
145
DELISTED
Kansas City Southern
KSU
| $1.07B | 0.16% |
9,435,758
+601,071
| +7% | +$68.5M |
|
146
Equity Residential
EQR
$24.2B
| $1.06B | 0.15% |
16,002,844
-742,707
| -4% | -$49.1M |
|
147
Sensata Technologies
ST
$6.72B
| $1.03B | 0.15% |
20,822,053
-1,591,011
| -7% | -$83.3M |
|
148
Molina Healthcare
MOH
$10.6B
| $1.03B | 0.15% |
6,895,738
-277,898
| -4% | -$35.5M |
|
149
Walmart Inc
WMT
$920B
| $1.01B | 0.15% |
32,345,256
-920,193
| -3% | -$28.1M |
|
|
BDXA
150
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $1.01B | 0.15% |
15,380,123
-91,847
| -0.6% | -$5.86M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.